U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Michos ED, Berger Z, Yeh HC, et al. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Aug. (Comparative Effectiveness Review, No. 135.)

Cover of Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease

Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease [Internet].

Show details

References

1.
Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS. Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. Journal of the American College of Cardiology. 2011 Oct 18;58(17):1819–24. [PubMed: 21962825]
2.
Venge P, James S, Jansson L, Lindahl B. Clinical performance of two highly sensitive cardiac troponin I assays. Clinical chemistry. 2009 Jan;55(1):109–16. [PubMed: 18988756]
3.
Hassan AK, Bergheanu SC, Hasan-Ali H, Liem SS, van der Laarse A, Wolterbeek R, et al. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. The American journal of cardiology. 2009 Mar 15;103(6):779–84. [PubMed: 19268731]
4.
Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest. 2004 May;125(5):1877–84. [PubMed: 15136402]
5.
Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clinical chemistry. 2007 Apr;53(4):552–74. [PubMed: 17384001]
6.
Mahajan VS, Jarolim P. How to interpret elevated cardiac troponin levels. Circulation. 2011 Nov 22;124(21):2350–4. [PubMed: 22105197]
7.
Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clinical chemistry. 2012 Nov;58(11):1574–81. [PubMed: 22983113]
8.
Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clinical chemistry. 2009 Jul;55(7):1303–6. [PubMed: 19478023]
9.
deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clinical chemistry. 2012 Sep;58(9):1342–51. [PubMed: 22791885]
10.
National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases Division of Kidney, Urologic, and Hematologic Diseases. United States Renal Data System 2011 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. 2011. Available at: http:​//wwwusrdsorg/2011​/pdf/v2_00_intro_11pdf.
11.
Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. Journal of the American College of Cardiology. 2001 Oct;38(4):991–8. [PubMed: 11583870]
12.
Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. Journal of the American Society of Nephrology : JASN. 2008 Sep;19(9):1643–52. [PubMed: 18322158]
13.
Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. Journal of the American College of Cardiology. 2012 Dec 11;60(23):2427–63. [PubMed: 23154053]
14.
Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004 Jan 6;109(1):23–5. [PubMed: 14691043]
15.
Ellis K, Dreisbach AW, Lertora JL. Plasma elimination of cardiac troponin I in end-stage renal disease. Southern medical journal. 2001 Oct;94(10):993–6. [PubMed: 11702827]
16.
Jaffe AS. Chasing troponin: how low can you go if you can see the rise? Journal of the American College of Cardiology. 2006 Nov 7;48(9):1763–4. [PubMed: 17084246]
17.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Journal of the American College of Cardiology. 2012 Oct 16;60(16):1581–98. [PubMed: 22958960]
18.
Dobre M, Brateanu A, Rashidi A, Rahman M. Electrocardiogram abnormalities and cardiovascular mortality in elderly patients with CKD. Clinical journal of the American Society of Nephrology : CJASN. 2012 Jun;7(6):949–56. [PubMed: 22461533]
19.
Wu AH, Jaffe AS, Apple FS, Jesse RL, Francis GL, Morrow DA, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clinical chemistry. 2007 Dec;53(12):2086–96. [PubMed: 17954494]
20.
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Journal of the American College of Cardiology. 2007 Aug 14;50(7):e1–e157. [PubMed: 17692738]
21.
Morrow DA, Cannon CP, Rifai N, Frey MJ, Vicari R, Lakkis N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA : the journal of the American Medical Association. 2001 Nov 21;286(19):2405–12. [PubMed: 11712935]
22.
Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE. Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature. The Canadian journal of cardiology. 2004 Oct;20(12):1212–8. [PubMed: 15494773]
23.
Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation. 2005 Nov 15;112(20):3088–96. [PubMed: 16286604]
24.
Goicoechea M, de Vinuesa SG, Gomez-Campdera F, Luno J. Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). Kidney international Supplement. 2005 Jan;(93):S35–8. [PubMed: 15613066]
25.
Goicoechea M, Garca de Vinuesa S, Gomez-Campdera F, Gutierrez MJ, Blanco P, Amann R, et al. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 May;43(5):846–53. [PubMed: 15112175]
26.
Iliou MC, Fumeron C, Benoit MO, Tuppin P, Calonge VM, Moatti N, et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2003 Sep;42(3):513–23. [PubMed: 12955679]
27.
Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of epidemiology and community health. 1998 Jun;52(6):377–84. [PMC free article: PMC1756728] [PubMed: 9764259]
28.
AHRQ. Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality; Rockville, MD: 2011. (AHRQ Publication No. 10(11)-EHC063-EF)
29.
AHQR. Methods Guide for Medical Test Reviews. Rockville, MD: 2010.
30.
Hardy RJ, Thompson SG. A likelihood approach to meta-analysis with random effects. Stat Med. 1996 Mar 30;15(6):619–29. [PubMed: 8731004]
31.
Cornell JE, Mulrow CD, Localio R, Stack CB, Meibohm AR, Guallar E, et al. Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change. Annals of internal medicine. 2014 Feb 18;160(4) [PubMed: 24727843]
32.
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. [PMC free article: PMC1920534] [PubMed: 17555582]
33.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414):557–60. (Clinical research ed) [PMC free article: PMC192859] [PubMed: 12958120]
34.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 Dec;50(4):1088–101. [PubMed: 7786990]
35.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–34. (Clinical research ed) [PMC free article: PMC2127453] [PubMed: 9310563]
36.
AHRQ. Grading the Strength of a Body of Evidence When Assessing Health Care Interventions -AHRQ and the Effective Health Care Program: An Update. Rockville, MD: 2012.
37.
Flores-Solis LM, Hernandez-Dominguez JL, Otero-Gonzalez A, Gonzalez-Juanatey JR. Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2012;32(6):809–18. [PubMed: 23169364]
38.
Sukonthasarn A, Ponglopisit S. Diagnostic level of cardiac troponin T in patients with chronic renal dysfunction, a pilot study. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2007 Sep;90(9):1749–58. [PubMed: 17957915]
39.
Alcalai R, Planer D, Culhaoglu A, Osman A, Pollak A, Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Archives of internal medicine. 2007 Feb 12;167(3):276–81. [PubMed: 17296884]
40.
Flores LM, Hernandez Dominguez JL, Otero A, Gonzalez Juanatey JR. [Cardiac troponin I determination in patients with chronic renal failure]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2006;26(1):107–12. [PubMed: 16649431]
41.
Noeller TP, Meldon SW, Peacock WF, Emerman CL, McErlean ES, Vanlente F, et al. Troponin T in elders with suspected acute coronary syndromes. The American journal of emergency medicine. 2003 Jul;21(4):293–7. [PubMed: 12898485]
42.
Fehr T, Knoflach A, Ammann P, Pei P, Binswanger U. Differential use of cardiac troponin T versus I in hemodialysis patients. Clinical nephrology. 2003 Jan;59(1):35–9. [PubMed: 12572929]
43.
McCullough PA, Nowak RM, Foreback C, Tokarski G, Tomlanovich MC, Khoury NE, et al. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2002 Dec;9(12):1389–96. [PubMed: 12460842]
44.
Ikeda J, Zenimoto M, Kita M, Mori M. [Usefulness of cardiac troponin I in patients with acute myocardial infarction]. Rinsho byori The Japanese journal of clinical pathology. 2002 Oct;50(10):982–6. [PubMed: 12451679]
45.
Apple FS, Christenson RH, Valdes R Jr, Andriak AJ, Berg A, Duh SH, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clinical chemistry. 1999 Feb;45(2):199–205. [PubMed: 9931041]
46.
Bhagavan NV, Goldstein AP, Honda SA, Uyehara J, Blaisdell J, Sugiyama C, et al. Role of cardiac troponin I in the evaluation of myocardial injury. Journal of clinical laboratory analysis. 1998;12(5):276–9. [PMC free article: PMC6808166] [PubMed: 9773957]
47.
Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1998 Jul;13(7):1709–12. [PubMed: 9681716]
48.
Chenevier-Gobeaux C, Meune C, Freund Y, Wahbi K, Claessens YE, Doumenc B, et al. Influence of age and renal function on high-sensitivity cardiac troponin T diagnostic accuracy for the diagnosis of acute myocardial infarction. The American journal of cardiology. 2013 Jun 15;111(12):1701–7. [PubMed: 23540652]
49.
Haaf P, Reichlin T, Twerenbold R, Hoeller R, Rubini Gimenez M, Zellweger C, et al. Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays. European heart journal. 2013 Jul 14 [PubMed: 23821402]
50.
Pfortmueller CA, Funk GC, Marti G, Leichtle AB, Fiedler GM, Schwarz C, et al. Diagnostic performance of high-sensitive troponin T in patients with renal insufficiency. The American journal of cardiology. 2013 Dec 15;112(12):1968–72. [PubMed: 24091183]
51.
Barthelemy O, Cayla G, Silvain J, O'Connor SA, Bellemain-Appaix A, Beygui F, et al. Optimal time for catheterization in NSTE-ACS patients with impaired renal function: Insights from the ABOARD Study. International journal of cardiology. 2012 Jul 12 [PubMed: 22795712]
52.
Acharji S, Baber U, Mehran R, Fahy M, Kirtane AJ, Lansky AJ, et al. Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial. Circulation Cardiovascular interventions. 2012 Apr;5(2):157–65. [PubMed: 22354934]
53.
Chew HC. Cardiac troponin T in acute coronary syndrome with renal insufficiency. Asian cardiovascular & thoracic annals. 2008 Aug;16(4):284–7. [PubMed: 18670019]
54.
Kontos MC, Jamal SM, Ornato JP, Tatum JL, Jesse RL, Anderson FP. Comparison of the modification of diet in renal disease and the Cockcroft-Gault equations for predicting mortality in patients admitted for exclusion of myocardial ischemia. The American journal of cardiology. 2008 Jul 15;102(2):140–5. [PubMed: 18602510]
55.
Melloni C, Alexander KP, Milford-Beland S, Newby LK, Szczech LA, Pollack CV, et al. Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease. Clinical cardiology. 2008 Mar;31(3):125–9. [PMC free article: PMC6653170] [PubMed: 18383049]
56.
Apple FS, Pearce LA, Doyle PJ, Otto AP, Murakami MM. Cardiac troponin risk stratification based on 99th percentile reference cutoffs in patients with ischemic symptoms suggestive of acute coronary syndrome: influence of estimated glomerular filtration rates. American journal of clinical pathology. 2007 Apr;127(4):598–603. [PubMed: 17369136]
57.
Bueti J, Krahn J, Karpinski M, Bohm C, Fine A, Rigatto C. Troponin I testing in dialysis patients presenting to the emergency room: does troponin I predict the 30-day outcome? Nephron Clinical practice. 2006;103(4):c129–36. [PubMed: 16636580]
58.
Kontos MC, Garg R, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Outcomes in patients admitted for chest pain with renal failure and troponin I elevations. American heart journal. 2005 Oct;150(4):674–80. [PubMed: 16209963]
59.
Kontos MC, Garg R, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Predictive power of ejection fraction and renal failure in patients admitted for chest pain without ST elevation in the troponin era. American heart journal. 2005 Oct;150(4):666–73. [PubMed: 16209962]
60.
Han JH, Lindsell CJ, Ryan RJ, Gibler WB. Changes in cardiac troponin T measurements are associated with adverse cardiac events in patients with chronic kidney disease. The American journal of emergency medicine. 2005 Jul;23(4):468–73. [PubMed: 16032613]
61.
Aviles RJ, Askari AT, Lindahl B, Wallentin L, Jia G, Ohman EM, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. The New England journal of medicine. 2002 Jun 27;346(26):2047–52. [PubMed: 12087140]
62.
Gruberg L, Fuchs S, Waksman R, Pichard AD, Kent KM, Laird JR, et al. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: a 12-month outcome analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2002 Feb;55(2):174–9. [PubMed: 11835642]
63.
Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clinical chemistry. 2000 Sep;46(9):1345–50. [PubMed: 10973864]
64.
Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE. Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study. Journal of the American College of Cardiology. 1999 Feb;33(2):471–8. [PubMed: 9973028]
65.
Geerse DA, van Berkel M, Vogels S, Kooman JP, Konings CJ, Scharnhorst V. Moderate elevations of high-sensitivity cardiac troponin I and B-type natriuretic peptide in chronic hemodialysis patients are associated with mortality. Clinical chemistry and laboratory medicine : CCLM / FESCC. 2012 Dec 10:1–8. [PubMed: 23241607]
66.
Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, Thamer C, et al. Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality. PloS one. 2012;7(10):e47610. [PMC free article: PMC3471860] [PubMed: 23077650]
67.
Kalaji FR, Albitar S. Predictive value of cardiac troponin T and I in hemodialysis patients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2012 Sep;23(5):939–45. [PubMed: 22982904]
68.
Hasegawa M, Ishii J, Kitagawa F, Kanayama K, Takahashi H, Ozaki Y, et al. Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis. Heart and vessels. 2012 Aug 23 [PubMed: 22914904]
69.
Scheven L, de Jong PE, Hillege HL, Lambers Heerspink HJ, van Pelt LJ, Kootstra JE, et al. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. European heart journal. 2012 Sep;33(18):2272–81. [PubMed: 22740385]
70.
Gaiki MR, DeVita MV, Michelis MF, Panagopoulos G, Rosenstock JL. Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay. International urology and nephrology. 2012 Dec;44(6):1841–5. [PubMed: 22311387]
71.
Shroff GR, Akkina SK, Miedema MD, Madlon-Kay R, Herzog CA, Kasiske BL. Troponin I levels and postoperative myocardial infarction following renal transplantation. American journal of nephrology. 2012;35(2):175–80. [PMC free article: PMC3326278] [PubMed: 22286592]
72.
Holden RM, Beseau D, Booth SL, Adams MA, Garland JS, Morton RA, et al. FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients. Hemodialysis international International Symposium on Home Hemodialysis. 2012 Jan;16(1):53–8. [PubMed: 22099949]
73.
McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, et al. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). American heart journal. 2011 Oct;162(4):748–55 e3. [PubMed: 21982669]
74.
Hallen J, Madsen L, Ladefoged S, Fagerland MW, Serebruany VL, Agewall S, et al. Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease. Scandinavian journal of urology and nephrology. 2011 Mar;45(2):151–8. [PubMed: 21091090]
75.
Codognotto M, Piccoli A, Zaninotto M, Mion MM, Ruzza L, Barchita A, et al. Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers. Journal of nephrology. 2010 Jul-Aug;23(4):465–71. [PubMed: 20540041]
76.
McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clinica chimica acta; international journal of clinical chemistry. 2010 Jul 4;411(13-14):936–9. [PubMed: 20298685]
77.
Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, et al. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Internal medicine journal. 2009 Dec;39(12):812–8. [PubMed: 20233242]
78.
Claes K, Bammens B, Evenepoel P, Kuypers D, Coosemans W, Darius T, et al. Troponin I is a predictor of acute cardiac events in the immediate postoperative renal transplant period. Transplantation. 2010 Feb 15;89(3):341–6. [PubMed: 20145526]
79.
Orea-Tejeda A, Sanchez-Gonzalez LR, Castillo-Martinez L, Valdespino-Trejo A, Sanchez-Santillan RN, Keirns-Davies C, et al. Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients. Cardiology journal. 2010;17(1):42–8. [PubMed: 20104456]
80.
Kostrubiec M, Labyk A, Pedowska-Wloszek J, Pacho S, Wojciechowski A, Jankowski K, et al. Assessment of renal dysfunction improves troponin-based short-term prognosis in patients with acute symptomatic pulmonary embolism. Journal of thrombosis and haemostasis : JTH. 2010 Apr;8(4):651–8. [PubMed: 20088923]
81.
Petrovic D, Stojimirovic BB. Cardiac troponins: outcome predictors in hemodialysis patients. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs. 2009;12(4):258–63. [PubMed: 20035399]
82.
Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, et al. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease. Kidney & blood pressure research. 2009;32(5):373–9. [PubMed: 19887825]
83.
Bagheri N, Taziki O, Falaknazi K. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2009 Sep;20(5):789–93. [PubMed: 19736474]
84.
Hickson LT, El-Zoghby ZM, Lorenz EC, Stegall MD, Jaffe AS, Cosio FG. Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009 Jun;9(6):1354–61. [PubMed: 19459818]
85.
Roberts MA, Hare DL, Macmillan N, Ratnaike S, Sikaris K, Ierino FL. Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis. Annals of clinical biochemistry. 2009 Jul;46(Pt 4):291–5. [PubMed: 19454539]
86.
Trape J, Perez A, Naval I, Escudero J, Comerma I, Sans A, et al. Nt-proBNP in haemodialysis patients: a preliminary study. Scandinavian journal of clinical and laboratory investigation. 2008;68(5):415–20. [PubMed: 19172698]
87.
Sahinarslan A, Guz G, Okyay K, Mutluay R, Yalcin R, Bali M, et al. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2008 Sep;36(6):382–7. [PubMed: 19155641]
88.
Kang EW, Na HJ, Hong SM, Shin SK, Kang SW, Choi KH, et al. Prognostic value of elevated cardiac troponin I in ESRD patients with sepsis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2009 May;24(5):1568–73. [PubMed: 19145004]
89.
Hocher B, Kalk P, Godes M, Liefeldt L, Ziebig R, Stasch JP, et al. Gender-dependent impact of risk factors for cardiovascular and non-cardiovascular mortality in end-stage renal disease patients on haemodialysis. Kidney & blood pressure research. 2008;31(5):360–6. [PubMed: 19023219]
90.
Hickson LJ, Cosio FG, El-Zoghby ZM, Gloor JM, Kremers WK, Stegall MD, et al. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008 Nov;8(11):2352–9. [PubMed: 18785956]
91.
Han SH, Choi HY, Kim DK, Moon SJ, Lee JE, Yoo TH, et al. Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease. American journal of nephrology. 2009;29(2):129–35. [PubMed: 18719346]
92.
Helleskov Madsen L, Ladefoged S, Hildebrandt P, Atar D. Comparison of four different cardiac troponin assays in patients with end-stage renal disease on chronic haemodialysis. Acute cardiac care. 2008;10(3):173–80. [PubMed: 18608043]
93.
Katerinis I, Nguyen QV, Magnin JL, Descombes E. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels. Renal failure. 2008;30(4):357–62. [PubMed: 18569907]
94.
Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Troponin T is an independent predictor of mortality in renal transplant recipients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2008 Mar;23(3):1019–25. [PubMed: 18065785]
95.
Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2007 Dec;50(6):1009–19. [PMC free article: PMC2408379] [PubMed: 18037101]
96.
Brunet P, Oddoze C, Paganelli F, Indreies M, Faure V, Opris-Saveanu A, et al. Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome. International journal of cardiology. 2008 Sep 26;129(2):205–9. [PubMed: 17662483]
97.
Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, et al. Cardiac biomarkers and survival in haemodialysis patients. European journal of clinical investigation. 2007 May;37(5):350–6. [PubMed: 17461980]
98.
Wang AY, Lam CW, Wang M, Chan IH, Goggins WB, Yu CM, et al. Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients. Clinical chemistry. 2007 May;53(5):882–9. [PubMed: 17395709]
99.
Lamb EJ, Kenny C, Abbas NA, John RI, Webb MC, Price CP, et al. Cardiac troponin I concentration is commonly increased in nondialysis patients with CKD: experience with a sensitive assay. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2007 Apr;49(4):507–16. [PubMed: 17386318]
100.
Feringa HH, Bax JJ, de Jonge R, Elhendy A, van Domburg RT, Dunkelgrun M, et al. Impact of glomerular filtration rate on minor troponin T elevations for risk assessment in patients undergoing operation for abdominal aortic aneurysm or lower extremity arterial obstruction. The American journal of cardiology. 2006 Dec 1;98(11):1515–8. [PubMed: 17126662]
101.
Kanwar M, Hashem M, Rosman H, Kamalakannan D, Cheema A, Ali A, et al. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients. The American journal of cardiology. 2006 Nov 1;98(9):1283–7. [PubMed: 17056347]
102.
Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Lui SF, et al. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney international. 2006 Aug;70(3):444–52. [PubMed: 16871255]
103.
Vichairuangthum K, Leowattana W, Ong-Ajyooth L, Pokum S. The relationship between serum concentration of cardiac troponin I in chronic renal failure patients and cardiovascular events. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2006 May;89(5):714–20. [PubMed: 16756060]
104.
Havekes B, van Manen JG, Krediet RT, Boeschoten EW, Vandenbroucke JP, Dekker FW. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2006 May;47(5):823–9. [PubMed: 16632021]
105.
Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Ischemia-modified albumin predicts mortality in ESRD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2006 Mar;47(3):493–502. [PubMed: 16490629]
106.
Sharma R, Gaze DC, Pellerin D, Mehta RL, Gregson H, Streather CP, et al. Cardiac structural and functional abnormalities in end stage renal disease patients with elevated cardiac troponin T. Heart (British Cardiac Society). 2006 Jun;92(6):804–9. [PMC free article: PMC1860676] [PubMed: 16216854]
107.
Conway B, McLaughlin M, Sharpe P, Harty J. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005 Dec;20(12):2759–64. [PubMed: 16188899]
108.
Abbas NA, John RI, Webb MC, Kempson ME, Potter AN, Price CP, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clinical chemistry. 2005 Nov;51(11):2059–66. [PubMed: 16166165]
109.
Troyanov S, Ly QH, Schampaert E, Ammann H, Lalumiere G, Madore F, et al. Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: a three year prospective study. Heart (British Cardiac Society). 2005 Sep;91(9):1227–8. [PMC free article: PMC1769112] [PubMed: 16103574]
110.
Sharma R, Pellerin D, Gaze DC, Shah JS, Streather CP, Collinson PO, et al. Dobutamine stress echocardiography and cardiac troponin T for the detection of significant coronary artery disease and predicting outcome in renal transplant candidates. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology. 2005 Oct;6(5):327–35. [PubMed: 15985387]
111.
Hojs R, Ekart R, Hojs Fabjan T, Balon BP, Gorenjak M. Cardiac troponin T (cTnT) in hemodialysis patients with asymptomatic and symptomatic atherosclerosis. Archives of medical research. 2005 Jul-Aug;36(4):367–71. [PubMed: 15950076]
112.
Duman D, Tokay S, Toprak A, Oktay A, Ozener IC, Unay O. Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005 May;20(5):962–7. [PubMed: 15741207]
113.
Abaci A, Ekici E, Oguzhan A, Tokgoz B, Utas C. Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value. Clinical cardiology. 2004 Dec;27(12):704–9. [PMC free article: PMC6654729] [PubMed: 15628116]
114.
Fernandez-Reyes MJ, Mon C, Heras M, Guevara P, Garcia MC, Sanchez R, et al. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. Journal of nephrology. 2004 Sep-Oct;17(5):721–7. [PubMed: 15593041]
115.
Bozbas H, Korkmaz ME, Atar I, Eroglu S, Ozin B, Yildirir A, et al. Serum levels of cardiac enzymes before and after renal transplantation. Clinical cardiology. 2004 Oct;27(10):559–62. [PMC free article: PMC6653974] [PubMed: 15553307]
116.
Ie EH, Klootwijk PJ, Weimar W, Zietse R. Significance of acute versus chronic troponin T elevation in dialysis patients. Nephron Clinical practice. 2004;98(3):c87–92. [PubMed: 15528943]
117.
Hussein M, Mooij J, Roujouleh H, Al Shenawi O. Cardiac troponin-I and its prognostic significance in a dialysis population. Hemodialysis international International Symposium on Home Hemodialysis. 2004 Oct 1;8(4):332–7. [PubMed: 19379438]
118.
Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clinical chemistry. 2004 Dec;50(12):2279–85. [PubMed: 15364888]
119.
Boulier A, Jaussent I, Terrier N, Maurice F, Rivory JP, Chalabi L, et al. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2004 Sep;19(9):2313–8. [PubMed: 15252159]
120.
Hung SY, Hung YM, Fang HC, Yeh JH, Hung GC, Wu CJ, et al. Cardiac troponin I and creatine kinase isoenzyme MB in patients with intradialytic hypotension. Blood purification. 2004;22(4):338–43. [PubMed: 15218282]
121.
Kertai MD, Boersma E, Klein J, Van Urk H, Bax JJ, Poldermans D. Long-term prognostic value of asymptomatic cardiac troponin T elevations in patients after major vascular surgery. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2004 Jul;28(1):59–66. [PubMed: 15177233]
122.
Hocher B, Ziebig R, Krause R, Asmus G, Neumayer HH, Liefeldt L, et al. Relaxin is an independent risk factor predicting death in male patients with end-stage kidney disease. Circulation. 2004 May 18;109(19):2266–8. [PubMed: 15136497]
123.
Roberts MA, Fernando D, Macmillan N, Proimos G, Bach LA, Power DA, et al. Single and serial measurements of cardiac troponin I in asymptomatic patients on chronic hemodialysis. Clinical nephrology. 2004 Jan;61(1):40–6. [PubMed: 14964456]
124.
Hocher B, Ziebig R, Altermann C, Krause R, Asmus G, Richter CM, et al. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. Journal of the American Society of Nephrology : JASN. 2003 Sep;14(9):2329–37. [PubMed: 12937310]
125.
Wood GN, Keevil B, Gupta J, Foley R, Bubtana A, McDowell G, et al. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: a 2 year prospective study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2003 Aug;18(8):1610–5. [PubMed: 12897102]
126.
Choy JB, Armstrong PW, Ulan RA, Campbell PM, Gourishankar S, Prosser CI, et al. Do cardiac troponins provide prognostic insight in hemodialysis patients? The Canadian journal of cardiology. 2003 Jul;19(8):907–11. [PubMed: 12876611]
127.
deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA : the journal of the American Medical Association. 2003 Jul 16;290(3):353–9. [PubMed: 12865376]
128.
Peetz D, Schutt S, Sucke B, Faldum A, Wandel E, Hafner G, et al. Prognostic value of troponin T, troponin I, and CK-MBmass in patients with chronic renal failure. Medizinische Klinik (Munich, Germany : 1983). 2003 Apr 15;98(4):188–92. [PubMed: 12715142]
129.
Beciani M, Tedesco A, Violante A, Cipriani S, Azzarito M, Sturniolo A, et al. Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2003 May;18(5):942–6. [PubMed: 12686669]
130.
Scott B, Deman A, Peeters P, Van den Branden C, Stolear JC, Van Camp G, et al. Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2003 Apr;18(4):737–42. [PubMed: 12637643]
131.
Farkouh ME, Robbins MJ, Zafar MU, Shimbo D, Davidson KW, Puttappa R, et al. Association between troponin I levels and mortality in stable hemodialysis patients. The American journal of medicine. 2003 Feb 15;114(3):224–6. [PubMed: 12637137]
132.
Lowbeer C, Stenvinkel P, Pecoits-Filho R, Heimburger O, Lindholm B, Gustafsson SA, et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. Journal of internal medicine. 2003 Feb;253(2):153–60. [PubMed: 12542555]
133.
Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002 Dec 3;106(23):2941–5. [PubMed: 12460876]
134.
Lowbeer C, Gutierrez A, Gustafsson SA, Norrman R, Hulting J, Seeberger A. Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2002 Dec;17(12):2178–83. [PubMed: 12454230]
135.
Yakupoglu U, Ozdemir FN, Arat Z, Haberal A, Agca E, Bilgin N. Can troponin-I predict cardiovascular mortality due to myocardial injury in hemodialysis patients? Transplantation proceedings. 2002 Sep;34(6):2033–4. [PubMed: 12270303]
136.
Mallamaci F, Zoccali C, Parlongo S, Tripepi G, Benedetto FA, Cutrupi S, et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002 Jul;40(1):68–75. [PubMed: 12087563]
137.
Deegan PB, Lafferty ME, Blumsohn A, Henderson IS, McGregor E. Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney international. 2001 Dec;60(6):2399–405. [PubMed: 11737616]
138.
Ishii J, Nomura M, Okuma T, Minagawa T, Naruse H, Mori Y, et al. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clinica chimica acta; international journal of clinical chemistry. 2001 Oct;312(1-2):69–79. [PubMed: 11580911]
139.
Lang K, Schindler S, Forberger C, Stein G, Figulla HR. Cardiac troponins have no prognostic value for acute and chronic cardiac events in asymptomatic patients with end-stage renal failure. Clinical nephrology. 2001 Jul;56(1):44–51. [PubMed: 11499658]
140.
Ooi DS, Zimmerman D, Graham J, Wells GA. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clinical chemistry. 2001 Mar;47(3):412–7. [PubMed: 11238290]
141.
Dierkes J, Domrose U, Westphal S, Ambrosch A, Bosselmann HP, Neumann KH, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation. 2000 Oct 17;102(16):1964–9. [PubMed: 11034946]
142.
Porter GA, Norton T, Bennett WM. Long term follow up of the utility of troponin T to assess cardiac risk in stable chronic hemodialysis patients. Clinical laboratory. 2000;46(9-10):469–76. [PubMed: 11034532]
143.
Heeschen C, Deu A, Langenbrink L, Goldmann BU, Hamm CW. Analytical and diagnostic performance of troponin assays in patients suspicious for acute coronary syndromes. Clinical biochemistry. 2000 Jul;33(5):359–68. [PubMed: 11018687]
144.
Ooi DS, Veinot JP, Wells GA, House AA. Increased mortality in hemodialyzed patients with elevated serum troponin T: a one-year outcome study. Clinical biochemistry. 1999 Nov;32(8):647–52. [PubMed: 10638948]
145.
Stolear JC, Georges B, Shita A, Verbeelen D. The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1999 Aug;14(8):1961–7. [PubMed: 10462278]
146.
Roppolo LP, Fitzgerald R, Dillow J, Ziegler T, Rice M, Maisel A. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study. Journal of the American College of Cardiology. 1999 Aug;34(2):448–54. [PubMed: 10440158]
147.
Mockel M, Schindler R, Knorr L, Muller C, Heller G Jr, Stork TV, et al. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 1999 Jun;14(6):1489–95. [PubMed: 10383013]
148.
Musso P, Cox I, Vidano E, Zambon D, Panteghini M. Cardiac troponin elevations in chronic renal failure: prevalence and clinical significance. Clinical biochemistry. 1999 Mar;32(2):125–30. [PubMed: 10211629]
149.
Porter GA, Norton T, Bennett WB. Troponin T, a predictor of death in chronic haemodialysis patients. European heart journal. 1998 Nov;19 Suppl N:N34–7. [PubMed: 9857937]
150.
Morton AR, Collier CP, Ali N, Dagnone LE. Cardiac troponin I in patients receiving renal replacement therapy. ASAIO journal (American Society for Artificial Internal Organs : 1992). 1998 Sep-Oct;44(5):M433–5. [PubMed: 9804466]
151.
Apple FS, Sharkey SW, Hoeft P, Skeate R, Voss E, Dahlmeier BA, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1997 Mar;29(3):399–403. [PubMed: 9041216]
152.
Wang AYM, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE. Sudden cardiac death in end-stage renal disease patients: A 5-year prospective analysis. NDT Plus. 2010;3:iii291.
153.
Svensson M, Gorst-Rasmussen A, Schmidt EB, Jorgensen KA, Christensen JH. NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clinical nephrology. 2009;71(4):380–6. [PubMed: 19356370]
154.
Ilva T, Lassus J, Siirila-Waris K, Melin J, Peuhkurinen K, Pulkki K, et al. Clinical significance of cardiac troponins I and T in acute heart failure. European journal of heart failure. 2008;10(8):772–9. [PubMed: 18599345]
155.
Le Goff C, Bovy C, Aldenhoff MC, Krzesinski JM, Chapelle JP. Three-year prognostic interest of cardiac troponin T (cTnT) and amino-terminal pro-B-natriuretic peptide (NT-proBNP) in hemodialyzed patients. Immuno-Analyse et Biologie Specialisee. 2007;22(6):377–83.
156.
Quiroga B, Verdalles U, Reque J, Garcia de Vinuesa S, Goicoechea M, Luno J. Cardiovascular events and mortality in chronic kidney disease (stages I-IV). Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 2013 Jul 19;33(4):539–45. [PubMed: 23897186]
157.
Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, de Jong PE, et al. Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients. Clinical research in cardiology : official journal of the German Cardiac Society. 2013 Jun;102(6):439–45. [PubMed: 23397594]
158.
Wolley M, Stewart R, Curry E, Davidson J, White H, Pilmore H. Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patients. Clinical Kidney Journal. 2013;6(4):402–9. [PMC free article: PMC4898328] [PubMed: 27293568]
159.
Levin A, Rigatto C, Barrett B, Madore F, Muirhead N, Holmes D, et al. Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2014 May;29(5):1037–47. [PubMed: 24371297]
160.
Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC nephrology. 2013;14:280. [PMC free article: PMC3878021] [PubMed: 24359445]
161.
Bayes-Genis A, Zamora E, de Antonio M, Galan A, Vila J, Urrutia A, et al. Soluble ST2 serum concentration and renal function in heart failure. Journal of cardiac failure. 2013 Nov;19(11):768–75. [PubMed: 24263122]
162.
Alam A, Palumbo A, Mucsi I, Barre PE, Sniderman AD. Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patients. BMC nephrology. 2013;14:247. [PMC free article: PMC4226253] [PubMed: 24206774]
163.
Hassan HC, Howlin K, Jefferys A, Spicer ST, Aravindan AN, Suryanarayanan G, et al. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clinical chemistry. 2014 Feb;60(2):389–98. [PubMed: 24185551]
164.
Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. European heart journal. 2007 Jul;28(13):1598–660. [PubMed: 17569677]
165.
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology. 2000 Sep;36(3):959–69. [PubMed: 10987628]
166.
Douketis JD, Crowther MA, Stanton EB, Ginsberg JS. Elevated cardiac troponin levels in patients with submassive pulmonary embolism. Archives of internal medicine. 2002 Jan 14;162(1):79–81. [PubMed: 11784223]
167.
Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE. Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension. 2010 Aug;56(2):210–6. [PubMed: 20606110]
168.
Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ. 2003 Sep 6;327(7414):530–4. (Clinical research ed) [PMC free article: PMC192894] [PubMed: 12958111]
169.
Allie DE, Hebert CJ, Patlola R, Lirtzman MD, Wyatt CH, Keller VA, et al. A review of the early experience with Targeted Renal Therapy for renal function preservation during endovascular and surgical treatments for cardiovascular disease. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2007 May;3(1):121–7. [PubMed: 19737695]
170.
Javed U, Aftab W, Ambrose JA, Wessel RJ, Mouanoutoua M, Huang G, et al. Frequency of elevated troponin I and diagnosis of acute myocardial infarction. The American journal of cardiology. 2009 Jul 1;104(1):9–13. [PubMed: 19576313]
171.
Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, Maisel AS. Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. The American journal of cardiology. 2001 Apr 15;87(8):994–9. A4. [PubMed: 11305993]
172.
Palamalai V, Murakami MM, Apple FS. Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction. Clinical biochemistry. 2013 Jul 11 [PubMed: 23850852]
173.
Dohi T, Kasai T, Miyauchi K, Takasu K, Kajimoto K, Kubota N, et al. Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome. Journal of cardiology. 2012 Dec;60(6):438–42. [PubMed: 23063662]
174.
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003 Oct 28;108(17):2154–69. [PubMed: 14581387]
175.
Apple FS. Counterpoint: Standardization of cardiac troponin I assays will not occur in my lifetime. Clinical chemistry. 2012 Jan;58(1):169–71. [PubMed: 21940657]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (5.8M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...